Girardin Jean-Louis1,2, Rebecca Robbins3,4, Natasha J Williams1, John P Allegrante5,6, David M Rapoport7, Alwyn Cohall6, Gbenga Ogedegbe1. 1. Department of Population Health, Center for Healthful Behavioral Change, NYU Grossman School of Medicine, New York, New York. 2. Department of Psychiatry, NYU Grossman School of Medicine, New York, New York. 3. Brigham and Women's Hospital, Boston, Massachusetts. 4. Harvard Medical School, Boston, Massachusetts. 5. Columbia University Teachers College, New York, New York. 6. Columbia University Mailman School of Public Health, New York, New York. 7. Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract
STUDY OBJECTIVES: In a randomized controlled trial, we compared the effect of the Tailored Approach to Sleep Health Education (TASHE) on obstructive sleep apnea (OSA) self-efficacy among community-dwelling blacks in New York City. METHODS:Study participants were 194 blacks at high risk for OSA based on the Apnea Risk Evaluation System. TASHE intervention was delivered via a Wi-Fi-enabled tablet, programmed to provide online access to culturally and linguistically tailored information designed to address unique barriers to OSA care among blacks. Blacks in the attention-controlled arm received standard sleep information via the National Sleep Foundation website. Blacks in both arms accessed online sleep information for 2 months. Outcomes (OSA health literacy, self-efficacy, knowledge and beliefs, and sleep hygiene) were assessed at baseline, at 2 months, and at 6 months. RESULTS: We compared outcomes in both arms based on intention-to-treat analysis using adjusted Generalized Linear Mixed Modeling. TASHE exposure significantly increased OSA self-efficacy (OSA outcome expectation [β = .5; 95% CI: .1-.9] and OSA treatment efficacy [β = 0.4; 95% CI: .0-.8]) at 2 months but not at 6 months. Additionally, TASHE exposure improved sleep hygiene at 6 months (β = 6.7; 95% CI: 2.2-11.3) but not at 2 months. CONCLUSIONS:Community-dwelling blacks exposed to TASHE materials reported increased OSA self-efficacy compared with standard sleep health education. Stakeholder-engaged, theory-based approaches, as demonstrated in the TASHE intervention, can be used successfully to deliver effective sleep health messages. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; URL: https://clinicaltrials.gov/ct2/show/NCT02507089; Identifier: NCT02507089.
RCT Entities:
STUDY OBJECTIVES: In a randomized controlled trial, we compared the effect of the Tailored Approach to Sleep Health Education (TASHE) on obstructive sleep apnea (OSA) self-efficacy among community-dwelling blacks in New York City. METHODS: Study participants were 194 blacks at high risk for OSA based on the Apnea Risk Evaluation System. TASHE intervention was delivered via a Wi-Fi-enabled tablet, programmed to provide online access to culturally and linguistically tailored information designed to address unique barriers to OSA care among blacks. Blacks in the attention-controlled arm received standard sleep information via the National Sleep Foundation website. Blacks in both arms accessed online sleep information for 2 months. Outcomes (OSA health literacy, self-efficacy, knowledge and beliefs, and sleep hygiene) were assessed at baseline, at 2 months, and at 6 months. RESULTS: We compared outcomes in both arms based on intention-to-treat analysis using adjusted Generalized Linear Mixed Modeling. TASHE exposure significantly increased OSA self-efficacy (OSA outcome expectation [β = .5; 95% CI: .1-.9] and OSA treatment efficacy [β = 0.4; 95% CI: .0-.8]) at 2 months but not at 6 months. Additionally, TASHE exposure improved sleep hygiene at 6 months (β = 6.7; 95% CI: 2.2-11.3) but not at 2 months. CONCLUSIONS: Community-dwelling blacks exposed to TASHE materials reported increased OSA self-efficacy compared with standard sleep health education. Stakeholder-engaged, theory-based approaches, as demonstrated in the TASHE intervention, can be used successfully to deliver effective sleep health messages. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; URL: https://clinicaltrials.gov/ct2/show/NCT02507089; Identifier: NCT02507089.
Authors: Stephen V Burks; Jon E Anderson; Matthew Bombyk; Rebecca Haider; Derek Ganzhorn; Xueyang Jiao; Connor Lewis; Andrew Lexvold; Hong Liu; Jiachen Ning; Alice Toll; Jeffrey S Hickman; Erin Mabry; Mark Berger; Atul Malhotra; Charles A Czeisler; Stefanos N Kales Journal: Sleep Date: 2016-05-01 Impact factor: 5.849
Authors: A Pandey; M Demede; F Zizi; O Abo Al Haija'a; F Nwamaghinna; Girardin Jean-Louis; Samy I McFarlane Journal: Curr Diab Rep Date: 2011-02 Impact factor: 4.810
Authors: Joule J Li; Sarah L Appleton; Gary A Wittert; Andrew Vakulin; R Douglas McEvoy; Nick A Antic; Robert J Adams Journal: Sleep Date: 2014-03-01 Impact factor: 5.849
Authors: Rebecca Robbins; Katherine A Dudley; Kristen N Monten; Colin Le; Sherry Hanes; Sanjay R Patel; Suzanne M Bertisch Journal: ATS Sch Date: 2022-01-04